Immunic Files Prospectus To Offer Up To 458.2M Shares Of Common Stock By The Selling Stockholders

Immunic has filed a prospectus to offer up to 458.2 million shares of common stock by selling stockholders. This filing is part of a strategy to increase liquidity and provide existing shareholders with an opportunity to sell their shares. The stock is traded under the ticker IMUX.